A professional firm provides management consulting and investment banking services in international corporate development to high technology companies. The firm has been active in the healthcare sector for over 20 years working with Japanese clients that are looking for new business and/or technology opportunities both in medical device and pharmaceutical sectors. Currently, the firm does not manage its own VC funds but has access to funds prepared for direct investments or through CVCs by the firm’s clients in Japan. The firm is interested in companies from the seed stage through to late-stage venture rounds. The size of Investments varies by stage ranging from $0.5 Million to $3 Million. The firm is particularly interested in companies that have strong strategic fit with the Japanese market.
The firm’s primary focus is on the intersection between IT and Life Science, including POCT, telemedicine, among others. Technologies involving sensors and materials science are also high focus areas. For therapeutics, the firm generally does not invest in single-asset companies; therapeutic platform technologies that have the potential to create multiple ‘shots on goal’ are preferred. The firm focuses on patients for whom there is high unmet need and no currently adequate treatments. Rare diseases are of high interest.
The firm seeks management teams that exhibit knowledge of how to create a corporate value out of a strong technology. The firm focuses on technologies that allow the firm’s clients to provide a value-add in joint R&D, manufacturing, or distribution.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Hot Investor Mandate: Firm With Strong Ties to Japanese Market Seeks to Invest in Companies in the Intersection of Life Sciences and Technology Addressing Unmet Medical Need
4 NovSubscribe
Life Science Nation
RESI Conference Series
Investor Platform Demo
Company Platform Demo
Next Phase Newsletter 
Leave a Reply